USE OF A KMO INHIBITOR FOR PRODUCING A PHARMACEUTICAL COMPOSITION

Details for Australian Patent Application No. 2002351693 (hide)

Owner METAGEN PHARMACEUTICALS GMBH

Inventors RUMP, Andreas

Pub. Number AU-A-2002351693

PCT Number PCT/DE02/04309

PCT Pub. Number WO2003/047571

Priority 101 59 215.9 28.11.01 DE

Filing date 20 November 2002

Wipo publication date 17 June 2003

International Classifications

A61K 031/42 - Oxazoles

A61K 031/426 - 1,3-Thiazoles

A61P 035/00 Antineoplastic agents

A61K 031/198

A61K 031/192

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 101 59 215.9 28.11.01 DE

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002351693

12 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351694-METHOD AND DEVICE FOR RESHAPING TUBES

2002351692-DIRECTED GAS INJECTION APPARATUS FOR SEMICONDUCTOR PROCESSING